Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -376,742 | -132,527 | -289,088 | -370,638 | -194,592 |
| Depreciation Amortization | -840 | -9,731 | 4,737 | 7,376 | 4,853 |
| Accounts payable and accrued liabilities | 1,807 | -7,578 | 2,373 | 818 | 60 |
| Other Working Capital | -102,827 | -114,436 | 236,158 | 121,244 | 73,484 |
| Other Operating Activity | 131,356 | 115,077 | 68,347 | 174,932 | 20,454 |
| Operating Cash Flow | $-347,246 | $-149,195 | $22,527 | $-66,268 | $-95,741 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,946 | -33,732 | -48,951 | -46,811 | -16,357 |
| Net Acquisitions | N/A | N/A | N/A | 620 | N/A |
| Purchase Of Investment | -486,439 | -984,338 | -1,616,999 | -777,223 | -282,362 |
| Sale Of Investment | 680,392 | 1,089,910 | 1,204,614 | 529,270 | 198,596 |
| Investing Cash Flow | $185,007 | $71,840 | $-461,336 | $-294,144 | $-100,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,221 | 279,331 | 114,065 | 767,075 | 3,155 |
| Other Financing Activity | -485 | -2,883 | -2,475 | -10,934 | 319,167 |
| Financing Cash Flow | $7,736 | $276,448 | $111,590 | $756,141 | $322,322 |
| Beginning Cash Position | 444,614 | 245,521 | 572,740 | 177,011 | 50,553 |
| End Cash Position | 290,111 | 444,614 | 245,521 | 572,740 | 177,011 |
| Net Cash Flow | $-154,503 | $199,093 | $-327,219 | $395,729 | $126,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -347,246 | -149,195 | 22,527 | -66,268 | -95,741 |
| Capital Expenditure | -8,946 | -33,732 | -48,951 | -46,811 | -16,357 |
| Free Cash Flow | -356,192 | -182,927 | -26,424 | -113,079 | -112,098 |